(4-甲氧基-3,5-二甲基苯基)甲醇 | 83037-98-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: (4-甲氧基-3,5-二甲基苯基)甲醇
• 英文名称: 4-hydroxymethyl-2,6-dimethylanisole
• 英文别名: (3,5-dimethyl-4-methoxyphenyl)methanol；(4-methoxy-3,5-dimethylphenyl)methanol；4-methoxy-3,5-dimethyl-benzyl alcohol；4-Methoxy-3,5-dimethyl-benzylalkohol
• CAS: 83037-98-3
• 化学式: C₁₀H₁₄O₂
• 分子量: 166.22
• InChiKey: NBUJBWNLLNTOTC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2909499000

反应信息

• 作为反应物：
  描述：

  (4-甲氧基-3,5-二甲基苯基)甲醇 在 potassium permanganate 、 氢溴酸 作用下， 生成 4-羟基-3,5-二甲基苯甲酸
  参考文献：
  名称：

  Andersen, 1956, vol. 19, # 1, p. 38

  摘要：

  DOI：
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 lithium aluminium tetrahydride 、 乙醚 作用下， 生成 (4-甲氧基-3,5-二甲基苯基)甲醇
  参考文献：
  名称：

  Baddeley et al., Journal of the Chemical Society, 1956, p. 2455,246

  摘要：

  DOI：

文献信息

• Kinetics and Mechanism of Hydrolysis of Labile Quaternary Ammonium Derivatives of Tertiary Amines
  作者：Joseph B. Bogardus、Takeru Higuchi

  DOI：10.1002/jps.2600710703

  日期：1982.7

  The kinetics and mechanism of hydrolysis of N-(4-hydroxy-3,5-dimethylbenzyl)pyridinium bromide and similar quaternary derivatives of niacinamide, N,N-dimethylaniline, and trimethylamine were investigated. pH-Rate profiles at 25 degrees for formation of tertiary amine and 4-hydroxymethyl-2,6-dimethylphenol indicated that the zwitterionic quaternary phenoxide was the reactive species in alkaline solution

  研究了N-（4-羟基-3,5-二甲基苄基）溴化吡啶和烟酰胺，N，N-二甲基苯胺和三甲胺的类似季铵衍生物的水解动力学和机理。在25度下形成叔胺和4-羟甲基-2,6-二甲基苯酚的pH值曲线表明，两性离子季酚盐是碱性溶液中的反应性物种。通过加入少量产物叔胺强烈抑制了表观水解速率，这与反应途径中存在中间体是一致的。提出了一种水解和甲醇分解这些化合物的机理，涉及可逆地形成醌甲基甲烷，4-亚甲基，-2,6-二甲基-2,5-环己二烯-1-酮，然后与溶剂或甲醇进行捕集反应。亲核试剂。用甲基或乙酰基取代酚氢极大地稳定了分子，这与所提出的机理一致。对于酯，胺的释放速率受酯基的特定碱催化水解的限制。这类化合物可用于叔胺的前药设计中。讨论了醌次甲基中间体在结构相似的药物（如肾上腺素）降解中的可能性。
• [EN] 4,5-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION<br/>[FR] COMPOSES D'IMIDAZOLYLE SUBSTITUES EN POSITIONS 4 ET 5, CONVENANT AU TRAITEMENT DE L'INFLAMMATION
  申请人：G.D. SEARLE & CO.

  公开号：WO1996003387A1

  公开（公告）日：1996-02-08

  (EN) A class of compounds is described for treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by formula (I), wherein R1 is selected from lower alkyl, lower haloalkyl, lower hydroxyalkyl, lower alkoxyalkyl, lower alkenyloxyalkyl, mercapto, lower alkylcarbonyl, lower haloalkylcarbonyl, phenylcarbonyl, lower aralkylcarbonyl, lower aralkenyl, lower aryloxyalkyl, lower aralkyloxyalkyl, lower arylsulfonyl, lower aralkylsulfonyl, lower arylthioalkyl, lower heteroarylalkylthioalkyl, and heteroaryl selected from 2-thienyl, 2-furyl, 3-furyl, 2-pyridyl, 4-pyridyl and 2-benzofuryl; wherein R2 and R3 are independently selected from heteroaryl, cycloalkyl and aryl, wherein the heteroaryl, cycloalkyl and aryl radicals are substituted at a substitutable position with one or more radicals selected from hydrido, halo, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, aminosulfonyl, lower alkyl, cyano, carboxyl, lower alkoxycarbonyl, lower haloalkyl, hydroxyl, lower alkoxy, lower hydroxyalkyl, lower alkoxyalkyl, lower haloalkoxy, amino, lower alkylamino, phenylamino and nitro; and wherein R4 is selected from hydrido, lower alkyl and acyl; or a pharmaceutically acceptable salt thereof.(FR) La présente invention concerne une classe de composés convenant au traitement de l'inflammation et des troubles liés à l'inflammation. Les composés concernés en l'occurrence sont décrits par la formule générale (I). Dans cette formule générale (I), 'R1' est choisi parmi alkyle inférieur, haloalkyle inférieur, hydroxyalkyle inférieur, alcoxyalkyle inférieur, alcényloxyalkyle inférieur, mercapto, alkylcarbonyle inférieur, haloalkylcarbonyle inférieur, phénylcarbonyle, aralkylcarbonyle inférieur, aralcényle inférieur, aryloxyalkyle inférieur, aralkyloxyalkyle inférieur, arylsulfonyle inférieur, aralkylsulfonyle inférieur, arylthioalkyle inférieur, hétéroarylalkylthioalkyle inférieur, et hétéroaryle choisi parmi 2-thiényle, 2-furyle, 3-furyle, 2-pyridyle, 4-pyridyle et 2-benzofuryle. Dans la formule générale (I), 'R2' et 'R3' sont choisis séparément parmi hétéroaryle, cycloalkyle et aryle, les radicaux hétéroaryle, cycloalkyle et aryle étant substitués à des positions admettant la substitution par un ou plusieurs radicaux choisis parmi hydrido, halo, alkylthio inférieur, alkylsulfinyle inférieur, alkylsulfonyle inférieur, aminosulfonyle, alkyle inférieur, cyano, carboxyle, alcoxycarbonyle inférieur, haloalkyle inférieur, hydroxyle, alcoxy inférieur, hydroxyalkyle inférieur, alcoxyalkyle inférieur, haloalcoxy inférieur, amino, alkylamino inférieur, phénylamino et nitro. Dans la formule générale (I), 'R4' est choisi parmi hydrido, alkyle inférieur et acyle. L'invention concerne également des sels de ces composés de formule générale qui sont pharmaceutiquement acceptables.

  描述了一类用于治疗炎症和炎症相关疾病的化合物。特别感兴趣的化合物由式（I）定义，其中R1从较低的烷基，较低的卤代烷基，较低的羟基烷基，较低的氧烷基，较低的烯氧基烷基，巯基，较低的烷基羰基，较低的卤代烷基羰基，苯基羰基，较低的芳基烷基羰基，较低的芳基烯基，较低的芳氧基烷基，较低的芳基氧烷基，较低的芳基磺酰基，较低的芳基烷基磺酰基，较低的芳基硫代烷基，较低的杂环芳基烷基硫代烷基和杂环芳基，所述杂环芳基选择自2-噻吩基，2-呋喃基，3-呋喃基，2-吡啶基，4-吡啶基和2-苯并呋喃基；其中R2和R3分别选择自杂环芳基，环烷基和芳基，其中杂环芳基，环烷基和芳基基团在可取代位置上用一个或多个基团进行取代，所述基团选择自氢基，卤素基，较低的烷基硫基，较低的烷基亚砜基，较低的烷基磺酰基，氨基磺酰基，较低的烷基，氰基，羧基，较低的烷氧基羰基，较低的卤代烷基，羟基，较低的氧烷基，较低的羟基烷基，较低的氧烷基烷基，较低的卤代氧烷基，氨基，较低的烷基氨基，苯基氨基和硝基；其中R4选择自氢基，较低的烷基和酰基；或其药学上可接受的盐。
• 4,5-subtstituted imdazolyl compounds for the treatment of inflammation
  申请人：G.D. Searle & Co.

  公开号：US20030050330A1

  公开（公告）日：2003-03-13

  A class of compounds is described for treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula I 1 wherein R 1 is selected from lower alkyl, lower haloalkyl, lower hydroxyalkyl, lower alkoxyalkyl, lower alkenyloxyalkyl, mercapto, lower alkylcarbonyl, lower haloalkylcarbonyl, phenylcarbonyl, lower aralkylcarbonyl, lower aralkenyl, lower aryloxyalkyl, lower aralkyloxyalkyl, lower arylsulfonyl, lower aralkylsulfonyl, lower arylthioalkyl, lower heteroarylalkylthioalkyl, and heteroaryl selected from 2 -thienyl, 2 -furyl, 3 -furyl, 2 -pyridyl, 4 -pyridyl and 2 -benzofuryl; wherein R 2 and R 3 are independently selected from heteroaryl, cycloalkyl and aryl, wherein the heteroaryl, cycloalkyl and aryl radicals are substituted at a substitutable position with one or more radicals selected from hydrido, halo, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, aminosulfonyl, lower alkyl, cyano, carboxyl, lower alkoxycarbonyl, lower haloalkyl, hydroxyl, lower alkoxy, lower hydroxyalkyl, lower alkoxyalkyl, lower haloalkoxy, amino, lower alkylamino, phenylamino and nitro; and wherein R 4 is selected from hydrido, lower alkyl and acyl; or a pharmaceutically-acceptable salt thereof.

  描述了一类化合物，用于治疗炎症和与炎症相关的疾病。特别感兴趣的化合物由公式I1定义，其中R1选自较低的烷基，较低的卤代烷基，较低的羟基烷基，较低的烷氧基烷基，较低的烯氧基烷基，巯基，较低的烷基羰基，较低的卤代烷基羰基，苯基羰基，较低的芳基烷基羰基，较低的芳基烯基，较低的芳氧基烷基，较低的芳基氧烷基，较低的芳基磺酰基，较低的芳基烷基磺酰基，较低的芳基硫代烷基，较低的杂芳基烷基硫代烷基，和杂芳基，所述杂芳基选自2-噻吩基，2-呋喃基，3-呋喃基，2-吡啶基，4-吡啶基和2-苯并呋喃基；其中R2和R3分别选自杂芳基，环烷基和芳基，所述杂芳基，环烷基和芳基基团在可取代的位置上用一个或多个基团选自氢，卤素，较低的烷基硫，较低的烷基亚砜，较低的烷基磺酰基，氨基磺酰基，较低的烷基，氰基，羧基，较低的烷氧基羰基，较低的卤代烷基，羟基，较低的烷氧基，较低的羟基烷基，较低的烷氧基烷基，较低的卤代芳基氧基，氨基，较低的烷基氨基，苯基氨基和硝基；其中R4选自氢，较低的烷基和酰基；或其药学上可接受的盐。
• 4,5-substituted imidazolyl compounds for the treatment of inflammation
  申请人：G D Searle & Co.

  公开号：US06426360B1

  公开（公告）日：2002-07-30

  A class of compounds is described for treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula wherein R1 is selected from lower alkyl, lower haloalkyl, lower hydroxyalkyl, lower alkoxyalkyl, lower alkenyloxyalkyl, mercapto, lower alkylcarbonyl, lower haloalkylcarbonyl, phenylcarbonyl, lower aralkylcarbonyl, lower aralkenyl, lower aryloxyalkyl, lower aralkyloxyalkyl, lower arylsulfonyl, lower aralkylsulfonyl, lower arylthioalkyl, lower heteroarylalkylthioalkyl, and heteroaryl selected from 2-thienyl, 2-furyl, 3-furyl, 2-pyridyl, 4-pyridyl and 2-benzofuryl; wherein R2 and R3 are independently selected from heteroaryl, cycloalkyl and aryl, wherein the heteroaryl, cycloalkyl and aryl radicals are substituted at a substitutable position with one or more radicals selected from hydrido, halo, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, aminosulfonyl, lower alkyl, cyano, carboxyl, lower alkoxycarbonyl, lower haloalkyl, hydroxyl, lower alkoxy, lower hydroxyalkyl, lower alkoxyalkyl, lower haloalkoxy, amino, lower alkylamino, phenylamino and nitro; and wherein R4 is selected from hydrido, lower alkyl and acyl; or a pharmaceutically-acceptable salt thereof.

  描述了一类用于治疗炎症和炎症相关疾病的化合物。特别感兴趣的化合物由以下式子定义：其中R1选自较低的烷基、较低的卤代烷基、较低的羟基烷基、较低的烷氧基烷基、较低的烯氧基烷基、巯基、较低的烷基羰基、较低的卤代烷基羰基、苯基羰基、较低的芳基烷基羰基、较低的芳基烯基、较低的芳氧基烷基、较低的芳基氧基烷基、较低的芳基磺酰基、较低的芳基烷基磺酰基、较低的芳基硫代烷基、较低的杂芳基烷基硫代烷基和选自2-噻吩基、2-呋喃基、3-呋喃基、2-吡啶基、4-吡啶基和2-苯并呋喃基的杂芳基；其中R2和R3独立选自杂芳基、环烷基和芳基，其中杂芳基、环烷基和芳基基团在可取代位置上用一个或多个基团选自氢、卤、较低的烷基硫、较低的烷基亚砜、较低的烷基磺酰基、氨基磺酰基、较低的烷基、氰基、羧基、较低的烷氧羰基、较低的卤代烷基、羟基、较低的烷氧基、较低的羟基烷基、较低的卤代烷氧基、氨基、较低的烷基氨基、苯基氨基和硝基；其中R4选自氢、较低的烷基和酰基；或其药学上可接受的盐。
• [EN] OLIGOPEPTIDE LINKER INTERMEDIATE AND PREPARATION METHOD THEREFOR<br/>[FR] INTERMÉDIAIRE DE LIEUR OLIGOPEPTIDIQUE ET SON PROCÉDÉ DE PRÉPARATION<br/>[ZH] 一种寡肽连接子中间体及其制备方法
  申请人：MABPLEX INT CO LTD

  公开号：WO2021077317A1

  公开（公告）日：2021-04-29

  提供了一种寡肽类连接子中间体及其制备方法，所述方法反应条件温和，几乎没有副反应发生，杂质较少，产物较纯且易于纯化。